Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus

Antiviral Research

Volumn 65, Issue 1, 2005, Pages 49-55

  Miwa, Naoko ^a   Kurosaki, Kunikazu ^a   Yoshida, Yoshihiro ^a   Kurokawa, Masahiko ^a   Saito, Shigeru ^a   Shiraki, Kimiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Acyclovir; Drug resistance; Infection; Varicella zoster virus; Vidarabine

Indexed keywords

ACICLOVIR; VIDARABINE; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INCUBATION TIME; INHIBITION KINETICS; MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VARICELLA ZOSTER VIRUS; VIRUS CULTURE; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

ACYCLOVIR; ANTIVIRAL AGENTS; CELL LINE; HERPESVIRUS 3, HUMAN; HUMANS; PLAQUE ASSAY; VIDARABINE; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 3;

EID: 11844280393     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.10.002     Document Type: Article

References (33)

1. K.K. Biron, and G.B. Elion In vitro susceptibility of varicella-zoster virus to acyclovir Antimicrob. Agents Chemother. 18 1980 443 447
2. D.M. Coen, and P.A. Schaffer Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1 Proc. Natl. Acad. Sci. U.S.A. 77 1980 2265 2269
3. G.H. Cohen Ribonucleotide reductase activity of synchronized KB cells infected with herpes simplex virus J. Virol. 9 1972 408 418
4. P. Collins, B.A. Larder, N.M. Oliver, S. Kemp, I.W. Smith, and G. Darby Characterization of a DNA polymerase mutant of herpes simplex virus form a severely immunocompromised patient receiving acyclovir J. Gen. Virol. 70 1989 375 382
5. G.B. Elion, P.A. Furman, J.A. Fyfe, P. de Miranda, L. Beauchamp, and H.J. Schaeffer The selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine Proc. Natl. Acad. Sci. U.S.A. 74 1977 5716 5720
6. H.J. Field, G. Darby, and P. Wildy Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus J. Gen. Virol. 49 1980 115 124
7. P.A. Furman, D.M. Coen, M.H. St. Clair, and P.A. Schaffer Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities J. Virol. 40 1981 936 941
8. T. Kamiyama, M. Kurokawa, and K. Shiraki Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir J. Gen. Virol. 82 2001 2761 2765
9. K.W. Knopf, E.R. Kaufman, and C. Crumpacker Physical mapping of drug resistance mutations defines an active center of the herpes simplex DNA polymerase enzyme J. Virol. 39 1981 746 757
10. M. Kurokawa, H. Sato, H. Ohyama, T. Hozumi, T. Namba, T. Kawana, and K. Shiraki Effects of traditional herb medicines against herpes simplex virus (HSV) type 2 and acyclovir-resistant HSV type 1 in vitro and in vivo J. Trad. Med. 12 1995 187 194
11. M. Kurokawa, H. Ochiai, K. Nakajima, and S. Niwayama Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus J. Gen. Virol. 71 1990 2149 2155
12. Y. Langelier, and G. Buttin Characterization of ribonucleotide reductase induction in BHK-21/C13 Syrian hamster cell line upon infection by herpes simplex virus (HSV) J. Gen. Virol. 57 1981 21 31
13. B.A. Larder, and G. Darby Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir Antimicrob. Agents Chemother. 29 1986 894 898
14. W.E.G. Muller, R.K. Zahn, R. Beyer, and D. Falke 9-β-d- arabinofuranosyladenine as a tool to study herpes simplex virus DNA replication in vitro Virology 76 1977 787 796
15. W.E.G. Muller, R.K. Zahn, K. Bittlingmaier, and D. Falke Inhibition of herpesvirus DNA synthesis by 9-β-d-arabinofuranosyladenine in cellular and cell-free systems Ann. N.Y. Acad. Sci. 284 1977 34 48
16. J.C. Pelling, J.C. Drach, and C. Shipman Jr. Internucleoside incorporation of arabinosyl-adenine into herpes simplex virus and mammalian cell DNA Virology 109 1981 323 335
17. J.E. Reardon, and T. Spector Herpes simplex virus type 1 DNA polymerase: mechanism of inhibition by acyclovir triphosphate J. Biol. Chem. 264 1989 7405 7411
18. P. Reusser, C. Cordonnier, H. Einsele, D. Engelhard, D. Link, A. Locasciulli, and P. Ljungman European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious diseases working party of the European group for blood and marrow transplantation (EBMT) Bone Marrow Transplant 17 1996 813 817
19. A.H. Ross, and C. Balakrishnan Toxicity of adenine arabinoside in humans J. Infect. Dis. 133 1976 A192 A198
20. S.L. Sacks, J.L. Smith, R.B. Pollard, V. Sawhney, A.S. Mahol, P. Gregory, T.C. Merigan, and W.S. Robinson Toxicity of vidarabine JAMA 241 1979 28 29
21. P.M. Schwartz, J. Novack, C. Shipman Jr., and J.C. Drach Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells Biochem. Pharmacol. 33 1984 2431 2438
22. D.H. Shepp, P.S. Dandliker, and J.D. Meyers Treatment of varicella-zoster virus infection in severely immunocompromised patients: a randomized comparison of acyclovir and vidarabine N. Engl. J. Med. 314 1986 208 212
23. C. Shipman Jr., S. Smith, R.H. Carlson, and J.C. Drach Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures Antimicrob. Agents Chemother. 9 1976 120 127
24. K. Shiraki, and R.W. Hyman The immediate early proteins of varicella zoster virus Virology 156 1987 423 426
25. K. Shiraki, J. Namazue, T. Okuno, K. Yamanishi, and M. Takahashi Novel sensitivity of acyclovir-resistant varicella-zoster virus to antiherpetic drugs Antiviral Chem. Chemother. 1 1990 373 376
26. K. Shiraki, T. Okuno, K. Yamanishi, and M. Takahashi Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV) J. Gen. Virol. 61 1982 255 269
27. R.A. Vere Hodge Famciclovir and penciclovir: the mode of action of famiciclovir including its conversion to penciclovir Antiviral Chem. Chemother. 4 1993 67 84
28. R.A. Vere Hodge, and Y.C. Cheng The mode of action of penciclovir Antiviral Chem. Chemother. 4 Suppl. 1 1993 13 24
29. R.J. Whitley, A. Arvin, C. Prober, S. Burchett, L. Corey, D. Powell, S. Plotkin, S. Starr, C. Alford, J. Conner The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection N. Engl. J. Med. 324 1991 444 449
30. R.J. Whitley, L.T. Ch'ien, R. Dolin, G.J. Galasso, C.A. Alford Jr. The Collaborative Study Group Adenine arabinoside therapy of herpes zoster in the immunosuppressed N. Engl. J. Med. 294 1976 1193 1199
31. R.J. Whitley, S.J. Soong, R. Dolin, R. Betts, C. Linnemann Jr., and C.A. Alford Jr. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients N. Engl. J. Med. 307 1982 971 975
32. R.J. Whitley, M. Levin, N. Barton, B.J. Hershey, G. Davis, R.E. Keeney, J. Whelchel, A.G. Diethelm, P. Kartus, and S.J. Soong Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy J. Infect. Dis. 150 1984 323 329
33. R.J. Whitley, J.W. Gnann Jr., D. Hinthorn, C. Liu, R.B. Pollard, F. Hayden, G.J. Mertz, M. Oxman, and S.J. Soong Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine J. Infect. Dis. 165 1992 450 455